http://wiki.ch-chainclinic.com/index.php?action=history&feed=atom&title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6
基石药业行业研究 - 版本历史
2026-04-05T04:02:23Z
本wiki的该页面的版本历史
MediaWiki 1.30.0
http://wiki.ch-chainclinic.com/index.php?title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=13566&oldid=prev
2017年12月7日 (四) 05:55 Jianjdandd
2017-12-07T05:55:33Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年12月7日 (四) 05:55的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >第5行：</td>
<td colspan="2" class="diff-lineno">第5行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#创新生物公司基石药业首轮融资1.5亿美元 专攻中国特色疾病-美通社PR-Newswire  http://www.prnasia.com/story/153340-1.shtml</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#创新生物公司基石药业首轮融资1.5亿美元 专攻中国特色疾病-美通社PR-Newswire  http://www.prnasia.com/story/153340-1.shtml</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#基石药业 PD-L1 单抗临床试验申请获国家食药监局受理-美通社PR-Newswire  http://www.prnasia.com/story/161089-1.shtml</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#基石药业 PD-L1 单抗临床试验申请获国家食药监局受理-美通社PR-Newswire  http://www.prnasia.com/story/161089-1.shtml</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#基石药业PD-L1单克隆抗体药物CS1001首次人体临床试验成功  http://www.chemdrug.com/news/232/13/60312.html</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#赛诺菲原亚太研发中心总裁江宁军出任基石药业 - 百济健康商城  https://www.baiji.com.cn/news/baiji_news/2016/0706/234624.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#赛诺菲原亚太研发中心总裁江宁军出任基石药业 - 百济健康商城  https://www.baiji.com.cn/news/baiji_news/2016/0706/234624.html</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#基石药业副总裁吕强博士：深耕肿瘤免疫，放眼国际市场癌症医讯_资讯频道_中国癌症防治网  http://www.cnkaw.com/zxpd/hot/201701/18101288.html</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#吕强_创新药物研发与应用大会_千人智库  http://conf.1000thinktank.com/pharma/88_1802.aspx</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#生命化学奖 | 专访基石药业副总裁吕强博士：深耕肿瘤免疫，放眼国际市场  https://mp.weixin.qq.com/s/3VDY9fdTPDHVXpIJHLWZdQ</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客  http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客  http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#基石药业苏州转化医学研究中心  https://mp.weixin.qq.com/s/PICsrTJ5AxxCHqanhL8z9A</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#基石药业副总裁：医药人，都有一种坚持的韧性  https://mp.weixin.qq.com/s/5ERluOVOXfxYUY6GztWHoQ</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===相关讨论===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===相关讨论===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#PD-1单抗来袭！BMS Opdivo在中国提交上市申请_新浪医药新闻  http://med.sina.com/article_detail_103_2_35891.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#PD-1单抗来袭！BMS Opdivo在中国提交上市申请_新浪医药新闻  http://med.sina.com/article_detail_103_2_35891.html</div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l12" >第12行：</td>
<td colspan="2" class="diff-lineno">第19行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#国内布局PD-1/PD-L1企业一览（上次漏了基石药业）  https://mp.weixin.qq.com/s/1weQ87H_QPMiXAazgSs5WA</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#国内PD-1临床试验这么多，专家都不够用了…【最全盘点，请收藏】  https://mp.weixin.qq.com/s/sbatDlkk4wGGWOmFrdomOA</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#国内PD-1临床试验这么多，专家都不够用了…【最全盘点，请收藏】  https://mp.weixin.qq.com/s/sbatDlkk4wGGWOmFrdomOA</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#2017年FDA批准的41个新药逐个评述_新浪医药新闻  http://med.sina.com/article_detail_103_2_37844.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#2017年FDA批准的41个新药逐个评述_新浪医药新闻  http://med.sina.com/article_detail_103_2_37844.html</div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=13565&oldid=prev
Jianjdandd：/* 相关讨论 */
2017-12-07T05:45:16Z
<p><span dir="auto"><span class="autocomment">相关讨论</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年12月7日 (四) 05:45的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l15" >第15行：</td>
<td colspan="2" class="diff-lineno">第15行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#2017年FDA批准的41个新药逐个评述_新浪医药新闻  http://med.sina.com/article_detail_103_2_37844.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#2017年FDA批准的41个新药逐个评述_新浪医药新闻  http://med.sina.com/article_detail_103_2_37844.html</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Nature综述：RNA药物极具想象空间，蓄势待发_新浪医药新闻  http://med.sina.com/article_detail_103_2_37627.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Nature综述：RNA药物极具想象空间，蓄势待发_新浪医药新闻  http://med.sina.com/article_detail_103_2_37627.html</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#PD-1的应用现状如何，对比放化疗是否更有优势？ - 知乎  https://www.zhihu.com/question/40791048</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#医麦客: 挑战致命脑瘤：基因疗法、CAR-T、DC疫苗、PD-1同台竞技，到底谁「更胜一筹」丨医麦精品汇 今天是2017年11月21日 农历十月初四 医麦客：为脑瘤患者提供更多治疗选择 2017年11月21日/医麦客 eMed... - 雪球  https://xueqiu.com/5603603160/96073162</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Stevevai1983: 百济神州的基本面发生了天翻地覆的变化 今天大新闻来了。 新基和百济深度合作。新基不愧是医药界的VC，而且给小弟的合作方案从来都很慷慨大方。 1：新基获得百济P... - 雪球  https://xueqiu.com/9518372158/88338634</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Stevevai1983: 百济神州关于和新基合作的电话会议内容 昨天新基宣布和百济深度合作。 网页链接 今天昨晚的电话会议放出来，我翻译一些比较重要的点和问答。 1：百济提前成为商业化... - 雪球  https://xueqiu.com/9518372158/88370711</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Stevevai1983: 百济神州的投资（投机）逻辑 我在32刀买了2.5%小仓位的$百济神州(BGNE)$ 。写一篇文章记录自己的想法，未来也好更新内容。 百济神州是一个中... - 雪球  https://xueqiu.com/9518372158/78747148</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div></div></div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div></div></div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=13564&oldid=prev
Jianjdandd：/* 相关讨论 */
2017-12-07T05:41:55Z
<p><span dir="auto"><span class="autocomment">相关讨论</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年12月7日 (四) 05:41的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l9" >第9行：</td>
<td colspan="2" class="diff-lineno">第9行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===相关讨论===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===相关讨论===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#PD-1单抗来袭！BMS Opdivo在中国提交上市申请_新浪医药新闻  http://med.sina.com/article_detail_103_2_35891.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#PD-1单抗来袭！BMS Opdivo在中国提交上市申请_新浪医药新闻  http://med.sina.com/article_detail_103_2_35891.html</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Stevevai1983: 浅谈PD1 本人不是制药专业出身。但是对医药非常感兴趣，也是投资的主要领域。下面是我对PD1的一些观点 1： PD1是极具商业价值跨... - 雪球  https://xueqiu.com/9518372158/81748527</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=13563&oldid=prev
Jianjdandd：/* 相关讨论 */
2017-12-07T05:40:17Z
<p><span dir="auto"><span class="autocomment">相关讨论</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年12月7日 (四) 05:40的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8" >第8行：</td>
<td colspan="2" class="diff-lineno">第8行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客  http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客  http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===相关讨论===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===相关讨论===</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#PD-1单抗来袭！BMS Opdivo在中国提交上市申请_新浪医药新闻  http://med.sina.com/article_detail_103_2_35891.html</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=13562&oldid=prev
2017年12月7日 (四) 05:37 Jianjdandd
2017-12-07T05:37:26Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年12月7日 (四) 05:37的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td>
<td colspan="2" class="diff-lineno">第7行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#赛诺菲原亚太研发中心总裁江宁军出任基石药业 - 百济健康商城  https://www.baiji.com.cn/news/baiji_news/2016/0706/234624.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#赛诺菲原亚太研发中心总裁江宁军出任基石药业 - 百济健康商城  https://www.baiji.com.cn/news/baiji_news/2016/0706/234624.html</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客  http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客  http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">===相关讨论===</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#盘点：PD-1/PD-L1领域六大事件 - 单抗药物专区 - 生物谷  http://news.bioon.com/article/6677891.html</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#目前已经上市的PD1药物汇总及最新进展-香港综合肿瘤中心  http://ioc.waikong.hk/xinwenzixun/720.html</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#国内PD-1临床试验这么多，专家都不够用了…【最全盘点，请收藏】  https://mp.weixin.qq.com/s/sbatDlkk4wGGWOmFrdomOA</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#2017年FDA批准的41个新药逐个评述_新浪医药新闻  http://med.sina.com/article_detail_103_2_37844.html</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Nature综述：RNA药物极具想象空间，蓄势待发_新浪医药新闻  http://med.sina.com/article_detail_103_2_37627.html</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div></div></div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div></div></div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E5%9F%BA%E7%9F%B3%E8%8D%AF%E4%B8%9A%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=13560&oldid=prev
Jianjdandd：以“category:行业研究 <div style="max-width:73%; background-color:#C1FFC1; border:0px solid #000000;"> #创新生物公司基石药业首轮融资1.5亿美元...”为内容创建页面
2017-12-07T05:24:26Z
<p>以“<a href="/wiki/%E5%88%86%E7%B1%BB:%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6" title="分类:行业研究">category:行业研究</a> <div style="max-width:73%; background-color:#C1FFC1; border:0px solid #000000;"> #创新生物公司基石药业首轮融资1.5亿美元...”为内容创建页面</p>
<p><b>新页面</b></p><div>[[category:行业研究]]<br />
<div style="max-width:73%;<br />
background-color:#C1FFC1;<br />
border:0px solid #000000;"><br />
#创新生物公司基石药业首轮融资1.5亿美元 专攻中国特色疾病-美通社PR-Newswire http://www.prnasia.com/story/153340-1.shtml<br />
#基石药业 PD-L1 单抗临床试验申请获国家食药监局受理-美通社PR-Newswire http://www.prnasia.com/story/161089-1.shtml<br />
#赛诺菲原亚太研发中心总裁江宁军出任基石药业 - 百济健康商城 https://www.baiji.com.cn/news/baiji_news/2016/0706/234624.html<br />
#王进｜从基石药业谈主动型投资六大特点_健康博客_新浪博客 http://blog.sina.com.cn/s/blog_73fb07ff0102wk6j.html<br />
</div></div>
Jianjdandd